Abstract
This paper investigates protamine I (PRM1) expression and its effects on proliferation, invasion and migration of colon cancer cells as well as its function in clinical diagnosis and prognosis. Gene chips were used to screen differentially expressed genes. PRM1 expression was detected by Western blotting and quantitative real time-polymerase chain reaction (qRT-PCR). Hematoxylin and eosin (HE) staining and immunohistochemistry were utilized to compare the expression of PRM1 from multiple differentiation levels of colon cancer tissues. Cell viability, cell apoptosis and cell cycle were tested using the MTT assay and flow cytometry. Cell invasion and migration capability were tested using the Transwell assay and wound healing. In vivo effects of PRM1 on colon cancer were explored using a xenograft model. PRM1 expression in serum was detected by enzyme-linked immunosorbent assay (ELISA). The expression level of PRM1 was significantly higher in colon cancer tissues and the staining degree of PRM1 in poorly-differentiated was stronger. pcDNA3.1-PRM1 decreased cell apoptosis while it increased the proliferation, cell invasion and migration. The si-PRM1 group displayed an opposite tendency. The serum PRM1 level was significantly higher and could serve as a diagnostic biomarker for colon cancer.
Acknowledgments
We would like to acknowledge the reviewers for their helpful comments on this paper. This work was partly supported by Industry Technology Research and Development Project of Jilin Province of China (2013C014-2), Scientific and Technological Development Project of Jilin Province of China (20140204028YY), Industry Technology Research and Development Project of Jilin Province of China (2014Y083).
References
American Cancer Society: Cancer Facts and Figures 2017. Atlanta, GA: American Cancer Society, 2016.Search in Google Scholar
Bakker, N., Cakir, H., Doodeman, H.J., and Houdijk, A.P. (2015). Eight years of experience with enhanced recovery after surgery in patients with colon cancer: impact of measures to improve adherence. Surgery 157, 1130–1136.10.1016/j.surg.2015.01.016Search in Google Scholar
Balhorn, R. (2007). The protamine family of sperm nuclear proteins. Genome Biol. 8, 227.10.1186/gb-2007-8-9-227Search in Google Scholar
Balhorn, R., Reed, S., and Tanphaichitr, N. (1988). Aberrant protamine 1/protamine 2 ratios in sperm of infertile human males. Experientia 44, 52–55.10.1007/BF01960243Search in Google Scholar
Bertelsen, C.A., Neuenschwander, A.U., Jansen, J.E., Wilhelmsen, M., Kirkegaard-Klitbo, A., Tenma, J.R., Bols, B., Ingeholm, P., Rasmussen, L.A., Jepsen, L.V., et al. (2015). Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 16, 161–168.10.1016/S1470-2045(14)71168-4Search in Google Scholar
Boame, N., Gresham, G., Jonker, D., Martel, G., Balaa, F., and Asmis, T. (2014). Use of chemotherapy and radiofrequency ablation to treat colorectal cancer metastases: a retrospective review of The Ottawa Hospital Cancer Centre over 7 years. Curr. Oncol. 21, e557–e563.10.3747/co.21.1929Search in Google Scholar PubMed PubMed Central
Bower, P.A., Yelick, P.C., and Hecht, N.B. (1987). Both P1 and P2 protamine genes are expressed in mouse, hamster, and rat. Biol. Reprod. 37, 479–488.10.1095/biolreprod37.2.479Search in Google Scholar PubMed
Braun, R.E. (1990). Temporal translational regulation of the protamine 1 gene during mouse spermatogenesis. Enzyme 44, 120–128.10.1159/000468752Search in Google Scholar PubMed
Brewer, L.R., Corzett, M., and Balhorn, R. (1999). Protamine-induced condensation and decondensation of the same DNA molecule. Science 286, 120–123.10.1126/science.286.5437.120Search in Google Scholar PubMed
Caballero, O.L. and Chen, Y.T. (2009). Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100, 2014–2021.10.1111/j.1349-7006.2009.01303.xSearch in Google Scholar PubMed
Chiang, E.P., Tsai, S.Y., Kuo, Y.H., Pai, M.H., Chiu, H.L., Rodriguez, R.L., and Tang, F.Y. (2014). Caffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathways. PLoS One 9, e99631.10.1371/journal.pone.0099631Search in Google Scholar PubMed PubMed Central
Cunningham, D. and Findlay, M. (1993). The chemotherapy of colon cancer can no longer be ignored. Eur. J. Cancer 29A, 2077–2079.10.1016/0959-8049(93)90036-FSearch in Google Scholar
Czito, B.G., Bendell, J., and Willett, C.G. (2006). Radiation therapy for resectable colon cancer. Is there a role in the modern chemotherapy era? Oncology 20, 179-187; discussion 187–178, 192.Search in Google Scholar
Domenjoud, L., Kremling, H., Burfeind, P., Maier, W.M., and Engel, W. (1991). On the expression of protamine genes in the testis of man and other mammals. Andrologia 23, 333–337.10.1111/j.1439-0272.1991.tb02575.xSearch in Google Scholar
Egner, J.R. (2010). Ajcc cancer staging manual. J. Am. Med. Assoc. 304, 1726–1727.10.1001/jama.2010.1525Search in Google Scholar
Johnson, P.A., Peschon, J.J., Yelick, P.C., Palmiter, R.D., and Hecht, N.B. (1988). Sequence homologies in the mouse protamine 1 and 2 genes. Biochim. Biophys. Acta 950, 45–53.10.1016/0167-4781(88)90071-1Search in Google Scholar
Kehoe, J. and Khatri, V.P. (2006). Staging and prognosis of colon cancer. Surg. Oncol. Clin. N. Am. 15, 129–146.10.1016/j.soc.2005.08.006Search in Google Scholar PubMed
Kirat, H.T., Ozturk, E., Lavery, I.C., and Kiran, R.P. (2012). The predictive value of preoperative carcinoembryonic antigen level in the prognosis of colon cancer. Am. J. Surg. 204, 447–452.10.1016/j.amjsurg.2011.11.007Search in Google Scholar PubMed
Lam, D.M. and Bruce, W.R. (1971). The biosynthesis of protamine during spermatogenesis of the mouse: extraction, partial characterization, and site of synthesis. J. Cell Physiol. 78, 13–24.10.1002/jcp.1040780104Search in Google Scholar PubMed
Llosa, N.J., Cruise, M., Tam, A., Wicks, E.C., Hechenbleikner, E.M., Taube, J.M., Blosser, R.L., Fan, H., Wang, H., Luber, B.S., et al. (2015). The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 5, 43–51.10.1158/1538-7445.AM2015-451Search in Google Scholar
Meklat, F., Zhang, Y., Shahriar, M., Ahmed, S.U., Li, W., Voukkalis, N., Wang, Z., Zhang, J., Mastulov, S., Jewell, A., et al. (2009). Identification of protamine 1 as a novel cancer-testis antigen in early chronic lymphocytic leukaemia. Br. J. Haematol. 144, 660–666.10.1111/j.1365-2141.2008.07502.xSearch in Google Scholar PubMed PubMed Central
Okada, Y., Tateishi, K., and Zhang, Y. (2010). Histone demethylase JHDM2A is involved in male infertility and obesity. J. Androl. 31, 75–78.10.2164/jandrol.109.008052Search in Google Scholar PubMed PubMed Central
Peschon, J.J., Behringer, R.R., Brinster, R.L., and Palmiter, R.D. (1987). Spermatid-specific expression of protamine 1 in transgenic mice. Proc. Natl. Acad. Sci. USA 84, 5316–5319.10.1073/pnas.84.15.5316Search in Google Scholar
Retief, J.D., Winkfein, R.J., Dixon, G.H., Adroer, R., Queralt, R., Ballabriga, J., and Oliva, R. (1993). Evolution of protamine P1 genes in primates. J. Mol. Evol. 37, 426–434.10.1007/BF00178872Search in Google Scholar
Sayer, J.M., Aniana, A., and Louis, J.M. (2012). Mechanism of dissociative inhibition of HIV protease and its autoprocessing from a precursor. J. Mol. Biol. 422, 230–244.10.1016/j.jmb.2012.05.024Search in Google Scholar
Shankaran, V., Jolly, S., Blough, D., and Ramsey, S.D. (2012). Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J. Clin. Oncol. 30, 1608–1614.10.1200/JCO.2011.37.9511Search in Google Scholar
Simpson, A.J., Caballero, O.L., Jungbluth, A., Chen, Y.T., and Old, L.J. (2005). Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 5, 615–625.10.1038/nrc1669Search in Google Scholar
Song, M.H., Ha, J.M., Shin, D.H., Lee, C.H., Old, L., and Lee, S.Y. (2012). KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer. Int. J. Oncol. 41, 1820–1826.10.3892/ijo.2012.1601Search in Google Scholar
Tabernero, J., Salazar, R., Casado, E., Martinelli, E., Gomez, P., and Baselga, J. (2004). Targeted therapy in advanced colon cancer: the role of new therapies. Ann Oncol 15 (Suppl. 4), iv55–iv62.10.1093/annonc/mdh905Search in Google Scholar
Talvinen, K., Tuikkala, J., Gronroos, J., Huhtinen, H., Kronqvist, P., Aittokallio, T., Nevalainen, O., Hiekkanen, H., Nevalainen, T., and Sundstrom, J. (2006). Biochemical and clinical approaches in evaluating the prognosis of colon cancer. Anticancer Res. 26, 4745–4751.Search in Google Scholar
van Duin, M., Broyl, A., de Knegt, Y., Goldschmidt, H., Richardson, P.G., Hop, W.C., van der Holt, B., Joseph-Pietras, D., Mulligan, G., Neuwirth, R., et al. (2011). Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy. Haematologica 96, 1662–1669.10.3324/haematol.2010.037978Search in Google Scholar
Weaver, M.L., Atkinson, D., and Zemel, R. (1995). Hepatic cryosurgery in treating colorectal metastases. Cancer 76, 210–214.10.1002/1097-0142(19950715)76:2<210::AID-CNCR2820760208>3.0.CO;2-SSearch in Google Scholar
Yoon, H., Lee, H., Kim, H.J., You, K.T., Park, Y.N., Kim, H., and Kim, H. (2011). Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer. Tohoku J. Exp. Med. 224, 41–46.10.1620/tjem.224.41Search in Google Scholar
Zhang, H., Mao, Y., Zhang, F., Ye, C., Tong, H., Su, Y. and Zhu, J. (2014). The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma. Mol. Cell Biochem. 391, 77–84.10.1007/s11010-014-1989-3Search in Google Scholar PubMed
Zhao, P., Yu, H.Z., and Cai, J.H. (2015). Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer. Mol. Med. Rep. 12, 4364–4369.10.3892/mmr.2015.3900Search in Google Scholar PubMed
Supplemental Material:
The online version of this article offers supplementary material (https://doi.org/10.1515/hsz-2017-0222).
©2018 Walter de Gruyter GmbH, Berlin/Boston